Mitchell Capital Management Co. Sells 39 Shares of Mettler-Toledo International, Inc. $MTD

Mitchell Capital Management Co. reduced its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 13.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 262 shares of the medical instruments supplier’s stock after selling 39 shares during the period. Mitchell Capital Management Co.’s holdings in Mettler-Toledo International were worth $313,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in MTD. Greenleaf Trust boosted its stake in Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock worth $1,030,000 after purchasing an additional 10 shares in the last quarter. Brooklyn Investment Group raised its position in shares of Mettler-Toledo International by 12.8% during the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock worth $104,000 after acquiring an additional 10 shares during the last quarter. Sax Wealth Advisors LLC raised its position in shares of Mettler-Toledo International by 2.8% during the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock worth $437,000 after acquiring an additional 10 shares during the last quarter. Sequoia Financial Advisors LLC raised its position in shares of Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock worth $740,000 after acquiring an additional 11 shares during the last quarter. Finally, Albion Financial Group UT raised its position in shares of Mettler-Toledo International by 1.5% during the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock worth $890,000 after acquiring an additional 11 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the transaction, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at $6,389,588.55. This trade represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,827 shares of company stock worth $2,371,208. 0.77% of the stock is owned by corporate insiders.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,274.39 on Monday. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,486.76. The business has a 50-day moving average of $1,278.97 and a two-hundred day moving average of $1,190.01. The company has a market capitalization of $26.25 billion, a P/E ratio of 32.27, a price-to-earnings-growth ratio of 3.82 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same period in the prior year, the company earned $9.65 earnings per share. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Barclays boosted their target price on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Citigroup upped their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Thursday, August 21st. Evercore ISI upped their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. JPMorgan Chase & Co. upped their price objective on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a report on Thursday. Finally, Bank of America upped their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Five equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average price target of $1,336.50.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.